Search results
Meet Namita Thapar, Shark Tank Judge Who is Raking in Nearly Rs 128 Crore via Emcure Pharma IPO -...
News18· 2 days agoNamita Thapar is a remarkably successful businesswoman who is also an investor on Shark Tank India...
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of...
The Economic Times· 4 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals will open for subscription on Wednesday,...
Shark Tank Judge Namita Thapar To Earn Rs 127 Crore From Emcure IPO
NDTV· 3 days agoNamita Thapar, the Executive Director of Emcure Pharmaceuticals, is set to earn approximately Rs...
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 5 days agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on...
Namita Thapar may gain ₹127 crore in Emcure Pharma IPO
Hindustan Times· 5 days agoThrough the IPO, Namita Thapar will offload a partial stake of about 12.68 lakh shares under the...
Shark Tank India's Namita Thapar to make a whopping amount of around Rs 127cr from her brand's IPO...
The Times of India· 4 days agoShark Tank India's Namita Thapar is to receive a whopping of around Rs 127 cr from her recent...
Who Is Namita Thapar, Shark Tank Judge Set To Earn Rs 127 Crore From IPO
NDTV· 3 days agoEntrepreneur Namita Thapar is set to reap a remarkable 293x return on her initial investment in...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 4 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita ...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 5 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Namita Thapar's Emcure Pharmaceuticals IPO opens today: All you need to know
Hindustan Times· 3 days agoEmcure IPO: The price range of the IPO is ₹960-1,008 per share and investors can bid for 14 shares...